Works in Clinical Lymphoma, Myeloma & Leukemia, 2010, Vol 10, Issue 3

Results: 31
    1
    2

    Ofatumumab Combined With Fludarabine and Cyclophosphamide (O-FC) Shows High Activity in Patients With Previously Untreated Chronic Lymphocytic Leukemia: Results From a Randomized, Multicenter, International, Two-Dose, Parallel-Group Phase II Trial.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2010, v. 10, n. 3, p. E33, doi. 10.3816/CLML.2010.n.043
    By:
    • Wierda, William G.;
    • Kipps, Thomas J.;
    • Dürig, Jan;
    • Griskevicius, Laimonas;
    • Stilgenbauer, Stephan;
    • Mayer, Jiri;
    • Smolej, Lukas;
    • Hess, Georg;
    • Griniute, Rasa;
    • Hernandez-Ilizaliturri, Francisco J.;
    • Padmanabhan, Swaminathan;
    • Gorczyca, Michele;
    • Gupta, Ira;
    • Nielsen, Tina G.;
    • Russell, Charlotte A.
    Publication type:
    Article
    3

    Response to Second-line Therapy Defines the Potential for Cure in Patients With Recurrent Diffuse Large B-Cell Lymphoma: Implications for the Development of Novel Therapeutic Strategies.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2010, v. 10, n. 3, p. 192, doi. 10.3816/CLML.2010.n.030
    By:
    • Elstrom, Rebecca L.;
    • Martin, Peter;
    • Ostrow, Katya;
    • Barrientos, Jacqueline;
    • Chadburn, Amy;
    • Furman, Richard;
    • Ruan, Jia;
    • Shore, Tsiporah;
    • Schuster, Michael;
    • Cerchietti, Leandro;
    • Melnick, Ari;
    • Coleman, Morton;
    • Leonard, John P.
    Publication type:
    Article
    4
    5

    Bone Loss in Lymphoma Patients Prior to Receiving Front-line Therapy.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2010, v. 10, n. 3, p. E32, doi. 10.3816/CLML.2010.n.042
    By:
    • Westin, Jason R.;
    • Thompson, Michael A.;
    • Cataldo, Vince D.;
    • Toth, Bela B.;
    • Sanjorjo, Perpetua;
    • Bourgeois, Scott;
    • Jimenez, Camilo;
    • Murphy, William A.;
    • Fanale, Michelle;
    • Fayad, Luis;
    • Fowler, Nathan;
    • Kwak, Larry;
    • McLaughlin, Peter;
    • Neelapu, Sattva;
    • Pro, Barbara;
    • Rodriguez, Alma;
    • Shah, Jatin;
    • Hagemeister, Fredrick B.
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23

    Risk-Adapted Therapy With Three or Six Cycles of Doxorubicin/Bleomycin/Vinblastine/Dacarbazine Plus Involved-Field Radiation Therapy in Hodgkin Lymphoma, Based on Prognosis at Diagnosis and Early Response: Results From the GATLA Study.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2010, v. 10, n. 3, p. 181, doi. 10.3816/CLML.2010.n.028
    By:
    • Pavlovsky, Santiago;
    • Corrado, Claudia;
    • Pavlovsky, Miguel A.;
    • Prates, María V.;
    • Zoppegno, Lucía;
    • Giunta, Mario;
    • Cerutti, Ider;
    • Palomino, Elsa;
    • Pagani, Fernando;
    • Lastiri, Francisco;
    • Bar, Daniel;
    • Bezares, Raimundo F.;
    • Avila, Graciela
    Publication type:
    Article
    24
    25
    26
    27
    28

    Pitfalls in the Diagnosis of Primary Amyloidosis.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2010, v. 10, n. 3, p. 177, doi. 10.3816/CLML.2010.n.027
    By:
    • Chee, Cheng E.;
    • Lacy, Martha Q.;
    • Dogan, Ahmet;
    • Zeldenrust, Steven R.;
    • Gertz, Morie A.
    Publication type:
    Article
    29
    30
    31